Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Melanoma 5Prostatic Neoplasms 3Neuroblastoma 3Neoplasm Metastasis 3Myelodysplastic Syndromes 3Multiple Myeloma 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Breast Neoplasms 3Brain Neoplasms 3Uveal Melanoma 2Pancreatic Neoplasms 2Osteosarcoma 2Oligodendroglioma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Leukemia 2Glioma 2Ganglioneuroblastoma 2Carcinoma, Renal Cell 2Astrocytoma 2Sarcoma 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Plasma Cell 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1

Interventions

Filgrastim 19Temozolomide 18Cyclophosphamide 16Carboplatin 15Etoposide 12Vincristine 11Peripheral Blood Stem Cell Transplantation 10Cisplatin 10Radiotherapy 9Irinotecan 9Thiotepa 8Granulocyte Colony-Stimulating Factor 7sonidegib 5Methotrexate 5sargramostim 4Vorinostat 4Magnetic Resonance Spectroscopy 4Lomustine 4Chemotherapy, Adjuvant 4Carmustine 4etoposide phosphate 3Topotecan 3Radiation 3Platinum 3Paclitaxel 3Oxaliplatin 3O(6)-benzylguanine 3Melphalan 3HhAntag691 3Granulocyte-Macrophage Colony-Stimulating Factor 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Medulloblastoma × Colony-Stimulating Factors × Clear all
NCT02444546 2023-04-24

Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors

Mayo Clinic

Phase 1 Completed
6 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioma, Medulloblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT00002594 2014-07-24

Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors

Children's Oncology Group

Phase 2 Completed
31 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡